Chemed Corporation $CHE Shares Bought by ProShare Advisors LLC

ProShare Advisors LLC grew its stake in shares of Chemed Corporation (NYSE:CHE) by 1.4% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 56,504 shares of the company’s stock after buying an additional 779 shares during the quarter. ProShare Advisors LLC’s holdings in Chemed were worth $27,513,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in CHE. Jump Financial LLC acquired a new position in shares of Chemed in the 1st quarter valued at about $2,777,000. Commerce Bank raised its holdings in Chemed by 246.6% in the first quarter. Commerce Bank now owns 5,216 shares of the company’s stock valued at $3,210,000 after buying an additional 3,711 shares during the period. Synovus Financial Corp lifted its position in Chemed by 47.9% during the first quarter. Synovus Financial Corp now owns 1,827 shares of the company’s stock valued at $1,124,000 after buying an additional 592 shares in the last quarter. Sequoia Financial Advisors LLC purchased a new stake in Chemed during the second quarter worth approximately $342,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Chemed in the first quarter worth $891,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Jefferies Financial Group raised shares of Chemed from a “hold” rating to a “buy” rating and raised their target price for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 30th. Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Bank of America lowered their target price on Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Finally, Royal Bank Of Canada dropped their target price on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $574.25.

Insider Buying and Selling

In related news, Director Patrick P. Grace sold 150 shares of Chemed stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total value of $69,508.50. Following the completion of the sale, the director owned 3,397 shares in the company, valued at approximately $1,574,135.83. The trade was a 4.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Kevin J. Mcnamara sold 3,000 shares of the company’s stock in a transaction on Friday, September 26th. The shares were sold at an average price of $461.28, for a total transaction of $1,383,840.00. Following the completion of the sale, the chief executive officer directly owned 96,197 shares in the company, valued at $44,373,752.16. This represents a 3.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 3.29% of the company’s stock.

Chemed Price Performance

Shares of CHE stock opened at $445.60 on Wednesday. The company’s fifty day moving average price is $445.11 and its two-hundred day moving average price is $485.61. The firm has a market capitalization of $6.31 billion, a P/E ratio of 23.56, a P/E/G ratio of 2.69 and a beta of 0.43. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing the consensus estimate of $5.39 by ($0.12). Chemed had a net margin of 11.02% and a return on equity of 25.89%. The business had revenue of $624.90 million for the quarter, compared to analyst estimates of $626.04 million. During the same quarter in the prior year, the business earned $5.64 earnings per share. The firm’s revenue was up 3.1% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, sell-side analysts anticipate that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Monday, November 17th will be issued a dividend of $0.60 per share. The ex-dividend date is Monday, November 17th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is currently 12.69%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.